AstraZeneca chief in need of a tonic - AstraZeneca chief in need of a tonic Company chief executive David Brennan is under pressure from investors as drug patents expire and with little in the pipeline to replace them Source: Pharmaceuticals companies news from the Financial Times Psychology, Special Needs & Health.